SARS-CoV-2 spike protein and other viral antigens — Drug Target

8 drugs 3 marketed 5 in Phase 3

All drugs that target SARS-CoV-2 spike protein and other viral antigens — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

inactivated viral vaccine · Inactivated viral vaccine · Convalescent plasma

Marketed (3)

Phase 3 pipeline (5)